Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancers|September 28, 2023
A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic BiopsiesJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.
Urologic Oncology|May 27, 2023
Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/ml and an abnormal digital rectal examination?Juan Morote, Natàlia Picola, Nahuel Paesano, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Efficacy of Prostate Biopsies via Transperineal and Transrectal Routes for Significant Prostate Cancer Detection: A Multicenter Paired-Matched StudyNahuel Paesano, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.
Life (Basel, Switzerland)|November 27, 2024
The Role of Digital Rectal Examination for Early Detection of Significant Prostate Cancer in the Era of Magnetic Resonance ImagingJuan Morote, Nahuel Paesano, Natàlia Picola, et al.
The Journal of Urology|August 27, 2025
A semen panel signature comprising sTWEAK Cytokine levels and expression of exomiR-221-3p and exomiR-222-3p for assessing prostate cancer prognosis, diagnostic utility, and detection of upgrading during active surveillanceMarta Alves-Santiago, Antonio Altuna-Coy, Pablo López-Ribelles, et al.
Cancers|April 14, 2025
Developing a Predictive Model for Significant Prostate Cancer Detection in Prostatic Biopsies from Seven Clinical Variables: Is Machine Learning Superior to Logistic Regression?Juan Morote, Berta Miró, Patricia Hernando, et al.
World Journal of Urology|July 10, 2024
External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitorsJuan Morote, Ángel Borque-Fernando, Luis M Esteban, et al.
Urologic Oncology|February 11, 2024
Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in CataloniaJuan Morote, Ángel Borque-Fernando, Luis E Esteban, et al.
Pageof 2